HUTCHMED (China) Ltd 13-HK:Hong Kong Stock Exchange

*Data is delayed | HKD
Last | 09/17/21 CTT
60.10quote price arrow up+0.40 (+0.67%)
Volume
449,000
52 week range
51.20 - 85.80
Loading...
  • Open59.70
  • Day High60.60
  • Day Low58.60
  • Prev Close59.70
  • 52 Week High85.80
  • 52 Week High Date06/30/21
  • 52 Week Low51.20
  • 52 Week Low Date06/30/21

Key Stats

  • Market Cap6,639.4M
  • Shares Out848.52M
  • 10 Day Average Volume660,637.58
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open59.70
  • Day High60.60
  • Day Low58.60
  • Prev Close59.70
  • 52 Week High85.80
  • 52 Week High Date06/30/21
  • 52 Week Low51.20
  • 52 Week Low Date06/30/21
  • Market Cap6,639.4M
  • Shares Out848.52M
  • 10 Day Average Volume660,637.58
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.92
  • P/E (TTM)-31.33
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On HUTCHMED (China) Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering...
Simon To
Chairman
Christian Hogg
Chief Executive Officer
Chig Fung Cheng
Chief Financial Officer
Address
22Nd Floor Hutchison House
10 Harcourt Road
00000
Hong Kong